Edding Genor Group Holdings Ltd Sustainability Reports
The company engages in the research, development, manufacturing, and commercialization of therapeutic therapeutics, oncology treatments, autoimmune drugs, and biopharmaceutical products.
Sector: Manufacturing
Country: China
Exchange: Hong Kong Stock Exchange
FIGI: BBG00XC7TCY3
13 reports from 2020 to 2025
